Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prevalence and prognostic role of PD-L1 in patients with gynecological cancers: A systematic review and meta-analysis
Hanlin Fu, Zhihui Fu, Meng Mao, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 189, pp. 104084-104084
Open Access | Times Cited: 11

Showing 11 citing articles:

The emerging and challenging role of PD-L1 in patients with gynecological cancers: An updating review with clinico-pathological considerations
Angela Santoro, Giuseppe Angelico, Frediano Inzani, et al.
Gynecologic Oncology (2024) Vol. 184, pp. 57-66
Open Access | Times Cited: 13
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols
Tricia R. Cottrell, Michael T. Lotze, Alaa M. Ali, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e010928-e010928
Open Access
Effectiveness and safety of PD-1/PD-L1 inhibitors monotherapy in patients with endometrial cancer
Wan Xiao-yan, Jiezheng Huang, Liu Huang, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Biomarker expression and impact on clinical outcomes in an international study of chemoradiation and MRI-based image-guided brachytherapy for locally advanced cervical cancer: BIOEMBRACE
Supriya Chopra, Tjalling Bosse, Nanda Horeweg, et al.
International Journal of Radiation Oncology*Biology*Physics (2024)
Open Access | Times Cited: 4
Unveiling immunogenic characteristics and neoantigens in endometrial cancer with POLE hotspot mutations for improved immunotherapy
Jian Huang, Shuang Song, Yihua Yin, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Immunosuppressive JAG2+ tumor‐associated neutrophils hamper PD‐1 blockade response in ovarian cancer by mediating the differentiation of effector regulatory T cells
Chenyang Wang, Moran Yang, Y C Zhong, et al.
Cancer Communications (2025)
Open Access
Bridging the divide: unveiling mutual immunological pathways of cancer and pregnancy
Teodora Maria Toadere, Andra Țichindeleanu, Daniela Andreea Bondor, et al.
Inflammation Research (2024) Vol. 73, Iss. 5, pp. 793-807
Closed Access | Times Cited: 2
Silencing of STEAP3 suppresses cervical cancer cell proliferation and migration via JAK/STAT3 signaling pathway
Zouyu Zhao, Panpan Yu, Yan Wang, et al.
Cancer & Metabolism (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Identifying Explainable Machine Learning Models and a Novel SFRP2+ Fibroblast Signature as Predictors for Precision Medicine in Ovarian Cancer
Ziyi Yang, Dandan Zhou, Jun Huang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16942-16942
Open Access | Times Cited: 3
Management of Cervical Cancer and Human Papillomavirus in Pregnancy
María Fernanda Calderón León, María Eugenia Ugarte Vega, Germania Elizabeth Yugcha Andino, et al.
IntechOpen eBooks (2024)
Open Access
WGCNA reveals a biomarker for cancer-associated fibroblasts to predict prognosis in cervical cancer
Zaoling Liu, Nan Chen, Rong Li, et al.
Journal of the Chinese Medical Association (2024) Vol. 87, Iss. 9, pp. 885-897
Closed Access
Page 1

Scroll to top